Key Drivers
- Solid Annual Returns
- Weak Liquidity Profile
- Negative Quarterly Cashflow
AIAI Summary
Cigna's low valuation is attractive only if technology-driven medical-cost savings translate into sustained free-cash-flow recovery; investors should wait for evidence that negative quarterly cash flow is timing-related and that utilization pressure is contained before underwriting a rerating.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Solid Annual Returns
- •Weak Liquidity Profile
- •Negative Quarterly Cashflow
Cigna offers attractive valuation and solid annual profitability, but weak liquidity, high leverage, and negative quarterly cash flow warrant caution.
Price Behavior
Key Price Behavior Insights:
- •Support holding
- •Momentum weakening
- •Reclaim resistance
CI is holding $274–$276 support, but its sharp reversal from $290.05 and position below the last-month average warrant caution unless it reclaims $280.90–$284.70.
Sharp 5% reversal from $290.05 to $275.28
Sentiment & News
Key News Insights:
- •AI Cost Controls
- •Integrated Benefits
- •Investor Day
Cigna's AI-driven cost controls and integrated benefits strengthen its growth outlook ahead of Investor Day, despite mixed institutional trading.
These initiatives may support Cigna's valuation and investor confidence through improved affordability and member engagement
Similar Companies in Healthcare
Other companies in the same sector with AI ratings